1. Home
  2. HVT vs REPL Comparison

HVT vs REPL Comparison

Compare HVT & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haverty Furniture Companies Inc.

HVT

Haverty Furniture Companies Inc.

HOLD

Current Price

$27.36

Market Cap

400.9M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

N/A

Current Price

$15.50

Market Cap

454.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HVT
REPL
Founded
1885
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.9M
454.6M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
HVT
REPL
Price
$27.36
$15.50
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$5.67
AVG Volume (30 Days)
132.7K
5.6M
Earning Date
05-05-2026
05-21-2026
Dividend Yield
6.05%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$758,995,000.00
N/A
Revenue This Year
$8.83
N/A
Revenue Next Year
$8.70
N/A
P/E Ratio
$35.56
N/A
Revenue Growth
4.99
N/A
52 Week Low
$19.90
$1.50
52 Week High
$29.83
$16.15

Technical Indicators

Market Signals
Indicator
HVT
REPL
Relative Strength Index (RSI) 56.28 61.95
Support Level $25.26 $8.79
Resistance Level $29.83 $15.71
Average True Range (ATR) 0.65 0.94
MACD -0.21 0.02
Stochastic Oscillator 40.46 78.31

Price Performance

Historical Comparison
HVT
REPL

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Share on Social Networks: